Literature DB >> 8877168

MR imaging of multiple sclerosis simulating brain tumor.

N Kurihara1, S Takahashi, A Furuta, S Higano, K Matsumoto, M Tobita, H Konno, K Sakamoto.   

Abstract

Multiple sclerosis may sometimes present as a mass lesion that is indistinguishable from brain tumor both clinically and radiologically. We describe two cases of multiple sclerosis simulating brain tumor on computed tomography (CT) scans and magnetic resonance (MR) images, one of which was proved and another was suggestive to be demyelinating disease by biopsy. Steroid therapy produced regression of the lesions of MR images and CT scans. Our cases and others in the literature suggest strategies for detecting multiple sclerosis presenting as a mass lesion.

Entities:  

Mesh：

Substances：

Year:  1996        PMID： 8877168     DOI： 10.1016/0899-7071(95)00012-7

Source DB:  PubMed          Journal:  Clin Imaging        ISSN： 0899-7071            Impact factor:   1.605


  8 in total

1.  Dynamic contrast-enhanced T2*-weighted MR imaging of tumefactive demyelinating lesions.

Authors:  S Cha; S Pierce; E A Knopp; G Johnson; C Yang; A Ton; A W Litt; D Zagzag
Journal:  AJNR Am J Neuroradiol       Date:  2001 Jun-Jul       Impact factor: 3.825

2.  Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients.

Authors:  G Balloy; J Pelletier; L Suchet; C Lebrun; M Cohen; P Vermersch; H Zephir; E Duhin; O Gout; R Deschamps; E Le Page; G Edan; P Labauge; C Carra-Dallieres; L Rumbach; E Berger; P Lejeune; P Devos; J-B N'Kendjuo; M Coustans; E Auffray-Calvier; B Daumas-Duport; L Michel; F Lefrere; D A Laplaud; C Brosset; P Derkinderen; J de Seze; S Wiertlewski
Journal:  J Neurol       Date:  2018-07-27       Impact factor: 4.849

3.  High-dose methotrexate is beneficial in parenchymal brain masses of uncertain origin suspicious for primary CNS lymphoma.

Authors:  Philipp Kiewe; Christoph Loddenkemper; Ioannis Anagnostopoulos; Mark Reinwald; Eckhard Thiel; Agnieszka Korfel
Journal:  Neuro Oncol       Date:  2007-02-14       Impact factor: 12.300

4.  Proton MR spectroscopy of tumefactive demyelinating lesions.

Authors:  Amit M Saindane; Soonmee Cha; Meng Law; Xiaonan Xue; Edmond A Knopp; David Zagzag
Journal:  AJNR Am J Neuroradiol       Date:  2002-09       Impact factor: 3.825

Review 5.  Perfusion MRI: the five most frequently asked clinical questions.

Authors:  Marco Essig; Thanh Binh Nguyen; Mark S Shiroishi; Marc Saake; James M Provenzale; David S Enterline; Nicoletta Anzalone; Arnd Dörfler; Àlex Rovira; Max Wintermark; Meng Law
Journal:  AJR Am J Roentgenol       Date:  2013-09       Impact factor: 3.959

6.  Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis.

Authors:  C F Lucchinetti; R H Gavrilova; I Metz; J E Parisi; B W Scheithauer; S Weigand; K Thomsen; J Mandrekar; A Altintas; B J Erickson; F König; C Giannini; H Lassmann; L Linbo; S J Pittock; W Brück
Journal:  Brain       Date:  2008-06-05       Impact factor: 13.501

7.  Multiple Large Tumefactive MS Plaques in a Young Man: A Diagnostic Enigma and Therapeutic Challenge.

Authors:  Hossein Kalanie; Ali Amini Harandi; Reza Bakhshandehpour; Daryoosh Heidari
Journal:  Case Rep Radiol       Date:  2012-07-12

8.  Demyelination as a harbinger of lymphoma: a case report and review of primary central nervous system lymphoma preceded by multifocal sentinel demyelination.

Authors:  Mark D Kvarta; Deva Sharma; Rudolph J Castellani; Robert E Morales; Stephen G Reich; Amy S Kimball; Robert K Shin
Journal:  BMC Neurol       Date:  2016-05-21       Impact factor: 2.474
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.